New evidence supports Deeplex® Myc-TB as the reference method for enhanced drug-resistant TB detection
The World Health Organization (WHO) has published a new alarming report on the global rise of antibiotic resistance. According to its estimates, one-sixth of common bacterial infections worldwide were resistant to treatments in 2023, and the trend continues to worsen. Infectious diseases are a major global health concern accounting for a significant proportion of deaths worldwide. The emergence of antimicrobial resistance makes these diseases an increasingly critical threat to human health. Between 2018 and 2023, resistance increased in more than 40% of the pathogen-antibiotic combinations monitored by the GLASS system…
GenoScreen and Clear Labs Announce the Launch of Clear Dx™ Deeplex® Myc-TB, an Automated Genomic Solution for Mycobacterium Characterization and TB Drug Resistance Detection
GenoScreen announces the launch of Clear Dx™ Deeplex® Myc-TB, developed in collaboration with Clear Labs.
This next-generation solution fully automates the widely adopted Deeplex® Myc-TB assay, enabling rapid and comprehensive detection of drug resistance mutations and genotyping of Mycobacterium tuberculosis complex (MTBC), and broad identification of non-tuberculous mycobacteria (NTM). The product is available for Research Use Only…
Exciting news in leprosy detection and surveillance. Think positive!
Although considered an extinct calamity, leprosy is an infectious disease still present in more than hundred countries. Drug resistant strains of the bacterium responsible, Mycobacterium leprae, are emerging in several parts of the world, and transmission routes of the pathogen are not fully understood. As it is impossible to grow the bacterium in culture, new methods of detection and surveillance are needed in order to achieve the WHO‘s ambitious target of a 70% reduction in the number of annual cases by the end of the decade. A study has described and evaluated a new molecular approach for diagnosis and surveillance developed by GenoScreen. The test, called Deeplex® Myc-Lep…